Lixte Biotechnology Holdings, Inc. Stock
Equities
LIXT
US5393193017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.882 USD | +0.07% | -10.49% | +22.64% |
Apr. 23 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
Mar. 27 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.29M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 5.35M | Net cash position 2023 | 4.2M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.28
x | P/E ratio 2023 |
-0.88
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.81% |
1 day | +0.07% | ||
1 week | -10.49% | ||
Current month | +4.42% | ||
1 month | -22.11% | ||
3 months | +40.59% | ||
6 months | +4.05% | ||
Current year | +22.64% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 22-06-16 | |
Director of Finance/CFO | 72 | 20-08-11 | |
Eric Forman
COO | Chief Operating Officer | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 22-06-14 |
Chief Executive Officer | 52 | 22-06-16 | |
Yun Yen
BRD | Director/Board Member | 70 | 18-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 2.882 | +0.07% | 8,687 |
24-05-01 | 2.88 | +4.35% | 7,419 |
24-04-30 | 2.76 | -12.10% | 18,682 |
24-04-29 | 3.14 | -3.68% | 6,124 |
24-04-26 | 3.26 | +1.24% | 4,162 |
Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+22.64% | 6.48M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- LIXT Stock